Study Comparing the Efficacy and Safety of ABT-874 to Etanercept and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Completed · Phase 3 · Has a placebo group

Conditions studied: Moderate to Severe Plaque Psoriasis

In brief

Compare the efficacy of ABT-874 versus etanercept in subjects with moderate to severe plaque psoriasis

Key facts

Study ID

NCT00710580

Run by

AbbVie (prior sponsor, Abbott)

People needed

350

Starts

2008-07-01

Expected to finish

2009-04-01

Last updated by the study team

2013-01-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of Psoriasis for 6 MO
• BSA 10%
• PASI 12 or above
• PGA 3 or above

You may not qualify if…

• Previous exposure to either etanercept or ABT-874

Where it is running

• Site Reference ID/Investigator# 9984 — Birmingham, Alabama, United States
• Site Reference ID/Investigator# 10605 — Birmingham, Alabama, United States
• Site Reference ID/Investigator# 10001 — Scottsdale, Arizona, United States
• Site Reference ID/Investigator# 10502 — Little Rock, Arkansas, United States
• Site Reference ID/Investigator# 9985 — Bakersfield, California, United States
• Site Reference ID/Investigator# 10661 — Irvine, California, United States
• Site Reference ID/Investigator# 14701 — Los Angeles, California, United States
• Site Reference ID/Investigator# 9785 — San Diego, California, United States
• Site Reference ID/Investigator# 10662 — Santa Monica, California, United States
• Site Reference ID/Investigator# 10642 — Vallejo, California, United States
• Site Reference ID/Investigator# 10263 — New Haven, Connecticut, United States
• Site Reference ID/Investigator# 10503 — Jacksonville, Florida, United States
• Site Reference ID/Investigator# 10266 — Miami, Florida, United States
• Site Reference ID/Investigator# 9901 — Miami, Florida, United States
• Site Reference ID/Investigator# 10501 — West Palm Beach, Florida, United States
• Site Reference ID/Investigator# 15201 — Alpharetta, Georgia, United States
• Site Reference ID/Investigator# 10762 — Atlanta, Georgia, United States
• Site Reference ID/Investigator# 10262 — Newnan, Georgia, United States
• Site Reference ID/Investigator# 9789 — Snellville, Georgia, United States
• Site Reference ID/Investigator# 10666 — Maywood, Illinois, United States
• Site Reference ID/Investigator# 15142 — Plainfield, Indiana, United States
• Site Reference ID/Investigator# 10265 — Louisville, Kentucky, United States
• Site Reference ID/Investigator# 15750 — Owensboro, Kentucky, United States
• Site Reference ID/Investigator# 9790 — Owensboro, Kentucky, United States
• Site Reference ID/Investigator# 9788 — Fort Gratiot, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.